Interestingly, reduced levels of fibulin-5 in breast cancer have been reported to be required for metastasis formation in the liver and lung by suppressing the activity of MMP9, a protease that remodels the ECM during metastatic niche formation and promotes metastatic outgrowth [20]. Here, FBLN5 is linked to breast cancer.